Login to Your Account



Eyeing Cancer Drugs, Aphton Acquiring Igeneon For $81M

By Karen Pihl-Carey


Thursday, December 16, 2004
Aphton Corp. entered a definitive agreement to acquire the privately held Vienna, Austria-based company Igeneon AG for more than $81 million in equity. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription